2023 - Research.com Best Female Scientist Award
Her scientific interests lie mostly in Internal medicine, Risk factor, Cancer, Odds ratio and Genetics. Her Internal medicine study integrates concerns from other disciplines, such as Endocrinology, Methylation and Oncology. Her study on Endocrinology also encompasses disciplines like
Her Risk factor research is multidisciplinary, relying on both Epidemiology, Basal cell carcinoma, Surgery and Confidence interval. The various areas that Margaret R. Karagas examines in her Cancer study include Lung cancer, Carcinoma, Toxicology and Environmental health. Her research integrates issues of Gastroenterology, XRCC1, Case-control study and Sunburn in her study of Odds ratio.
Her main research concerns Internal medicine, Bladder cancer, Cancer, Odds ratio and Case-control study. Her Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology, Oncology and Pathology. Bladder cancer is a subfield of Genetics that she investigates.
Her work carried out in the field of Cancer brings together such families of science as Methylation, DNA methylation, Basal cell carcinoma, Environmental exposure and Epigenetics. Her work investigates the relationship between Odds ratio and topics such as Skin cancer that intersect with problems in Immunology, Dermatology and Sunburn. Her work in Risk factor tackles topics such as Surgery which are related to areas like Epidemiology.
Margaret R. Karagas spends much of her time researching Physiology, Pregnancy, Cohort, Internal medicine and Bladder cancer. Margaret R. Karagas interconnects Wechsler Adult Intelligence Scale, Urinary system and Environmental health in the investigation of issues within Pregnancy. Her work deals with themes such as Rate ratio, Fetus, Asthma and Methylation, which intersect with Cohort.
Her Oncology research extends to the thematically linked field of Internal medicine. Her Bladder cancer study combines topics from a wide range of disciplines, such as Odds ratio, microRNA, Smoking status and Nutritional epidemiology. As part of one scientific family, Margaret R. Karagas deals mainly with the area of Odds ratio, narrowing it down to issues related to the Confidence interval, and often Logistic regression, Lung cancer and Carcinoma.
Physiology, Obesity, Prospective cohort study, Microbiome and Environmental health are her primary areas of study. Her Physiology research incorporates themes from Offspring, Methylation, Placenta, Fetus and CpG site. She has included themes like Delivery mode, Social skills, Confounding and Autism in her Microbiome study.
Her work on Tobacco smoke as part of general Environmental health research is often related to Phthalate, thus linking different fields of science. Her Confidence interval study deals with Tattoo Site intersecting with Odds ratio. Her Odds ratio study is concerned with the larger field of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995))
Xifeng Wu;Yuanqing Ye;Lambertus A. Kiemeney;Patrick Sulem.
Nature Genetics (2009)
Aging and Environmental Exposures Alter Tissue-Specific DNA Methylation Dependent upon CpG Island Context
Brock C. Christensen;E. Andres Houseman;E. Andres Houseman;Carmen J. Marsit;Shichun Zheng.
PLOS Genetics (2009)
Evidence on the human health effects of low-level methylmercury exposure.
Margaret R. Karagas;Anna Lai Choi;Emily Oken;Milena Horvat.
Environmental Health Perspectives (2012)
Basic epidemiology of fractures of the upper and lower limb among Americans over 65 years of age.
John A. Baron;Margaret Karagas;Jane Barrett;Wayne Kniffin.
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
Nathaniel Rothman;Montserrat Garcia-Closas;Nilanjan Chatterjee;Nuria Malats.
Nature Genetics (2010)
Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group.
M R Karagas;T A Stukel;E R Greenberg;J A Baron.
Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA
M R Karagas;E R Greenberg;S K Spencer;T A Stukel.
International Journal of Cancer (1999)
Use of Tanning Devices and Risk of Basal Cell and Squamous Cell Skin Cancers
Margaret R. Karagas;Virginia A. Stannard;Leila A. Mott;Mary Jo Slattery.
Journal of the National Cancer Institute (2002)
New common variants affecting susceptibility to basal cell carcinoma
Simon N Stacey;Patrick Sulem;Gisli Masson;Sigurjon A Gudjonsson.
Nature Genetics (2009)
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls
Yu Mei Chang;Jennifer H. Barrett;Timothy D. Bishop;Bruce K. Armstrong.
International Journal of Epidemiology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: